ABSTRACT
Renal FMD occurs in younger patients with a female preponderance and often involves secondary or distal branches; FMD may also coexist in other vascular beds including the coronary circulation. Renal artery revascularization for patients with renal FMD can often be curative with respect to hypertension control. Historically, surgical revascularization or percutaneous transluminal angioplasty (PTA) has been utilized; stenting has not been felt to have a beneficial role in percutaneous treatment of FMD above and beyond the benefit observed with PTA alone (Fig. 1).
